MindWalk Files EU Patent for High-Dimensional Bio Data Layer
CERT•MindWalk filed European patent application EP26187897.9 to protect its high-dimensional biological data structures under HYFT, ReefIQ, and LensAI platforms. This secures a proprietary data layer as AI models commoditize and aligns with projected drug discovery AI spending rising from US$5B in 2026 to US$8B by 2030.
1. Patent Application Details
MindWalk submitted European patent application EP26187897.9 covering high-dimensional data structures for biological subsequences and property inference. The filing aims to protect the enriched biological representation architecture that underpins its HYFT Technology, ReefIQ context layer, and LensAI reasoning workflows.
2. Strategic Rationale
The company argues that as frontier AI models become interchangeable, lasting advantage resides in proprietary, structured data. This patent adds a distinct computational layer on top of its foundational HYFT patent to ensure traceable, context-rich biological knowledge retrieval and reuse across programs.
3. Market and Growth Outlook
The move aligns with forecasts of AI spending in drug discovery growing from US$5 billion in 2026 to over US$8 billion by 2030. By securing the data layer, MindWalk addresses fragmented biological data challenges and positions itself in the expanding life-sciences AI market.
